SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 220 filers reported holding SEATTLE GENETICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $34,000 | +21.4% | 400 | 0.0% | 0.03% | +28.6% |
| Q2 2019 | $28,000 | -3.4% | 400 | 0.0% | 0.02% | -8.7% |
| Q1 2019 | $29,000 | +11.5% | 400 | -11.5% | 0.02% | +15.0% |
| Q4 2018 | $26,000 | -25.7% | 452 | 0.0% | 0.02% | -13.0% |
| Q3 2018 | $35,000 | +29.6% | 452 | +13.0% | 0.02% | +15.0% |
| Q2 2018 | $27,000 | +28.6% | 400 | 0.0% | 0.02% | +150.0% |
| Q1 2018 | $21,000 | 0.0% | 400 | 0.0% | 0.01% | +14.3% |
| Q4 2017 | $21,000 | -4.5% | 400 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $22,000 | +4.8% | 400 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $21,000 | -16.0% | 400 | 0.0% | 0.01% | -30.0% |
| Q1 2017 | $25,000 | +19.0% | 400 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $21,000 | -4.5% | 400 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $22,000 | +37.5% | 400 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $16,000 | +14.3% | 400 | 0.0% | 0.01% | +33.3% |
| Q1 2016 | $14,000 | -22.2% | 400 | 0.0% | 0.01% | -33.3% |
| Q4 2015 | $18,000 | +20.0% | 400 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $15,000 | -21.1% | 400 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $19,000 | +35.7% | 400 | 0.0% | 0.01% | +12.5% |
| Q1 2015 | $14,000 | -56.2% | 400 | -60.0% | 0.01% | -66.7% |
| Q4 2014 | $32,000 | – | 1,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
| Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
| Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
| Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
| DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
| Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
| EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
| Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
| CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |